PharmaXcelerate USA Biopharma Manufacturing, Scale-Up & Commercial Readiness 

<p><!-- wp:paragraph --></p> <p>PharmaXcelerate USA 2026 brings together senior manufacturing leaders, engineers, and decision-makers from biopharma and biotech to tackle one central challenge: scaling complex therapies into commercial reality. Taking place September 15–16, 2026 in Philadelphia, this edition focuses on manufacturing scale-up, facility strategy, and operational readiness.</p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p>Delegates will engage with experts from AstraZeneca, Pfizer, Biogen, Moderna, Takeda, CSL Behring, and Eli Lilly, exploring real-world case studies on multi-modality facility design, Annex 1 compliance, scaling biologics and advanced therapies, MS&T transformation, and AI-driven manufacturing systems.</p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p>Join your peers in Philadelphia to exchange lessons learned and explore the strategies shaping the future of biopharma manufacturing in the US.</p> <p><!-- /wp:paragraph --></p> <p><!-- wp:paragraph --></p> <p><!-- /wp:paragraph --></p>